Young-Ho Moon

Title: Young-Ho Moon: Innovator in Molecular Targeted Therapy

Introduction

Young-Ho Moon is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of molecular targeted therapy, particularly in the treatment of hepatocellular carcinoma. His innovative approach aims to enhance the effectiveness of existing treatments for patients suffering from this challenging condition.

Latest Patents

Young-Ho Moon holds a patent for an analytical method designed to increase susceptibility to molecular targeted therapy in hepatocellular carcinoma. This method involves analyzing the mRNA expression of FGFR1, along with other biomarkers such as VEGFR2, PDGFRβ, c-KIT, c-RAF, EGFR, and mTOR. By determining whether a patient has susceptibility or resistance to sorafenib treatment, this analytical method allows for more personalized and effective treatment strategies.

Career Highlights

Young-Ho Moon is currently employed at Cbs Bioscience, Co., Ltd., where he continues to develop innovative solutions in the field of biotechnology. His work focuses on improving patient outcomes through advanced analytical methods and targeted therapies.

Collaborations

Young-Ho Moon collaborates with talented professionals in his field, including Jin-Young Park and Jung-Hee Kwon. These partnerships enhance the research and development efforts at Cbs Bioscience, Co., Ltd.

Conclusion

Young-Ho Moon's contributions to molecular targeted therapy represent a significant advancement in the treatment of hepatocellular carcinoma. His innovative analytical methods pave the way for more effective and personalized treatment options for patients.